[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Integumen Plc LSE:SKIN London Ordinary Share GB00BMGWZY29 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 28.00 28.00 29.00 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Personal Goods 0.8 -2.4 0.3 93.3 32

Deepverge PLC Microtox(R) PD installations as part of nat'l trial

28/10/2021 7:00am

RNS Non-Regulatory


TIDMDVRG

Deepverge PLC

28 October 2021

28 October 2021

DeepVerge PLC

("DeepVerge" or "Company")

Microtox(R) PD installations to be part of a

Government National COVID Infrastructure Trial

Modern Water, a division of DeepVerge (AIM: DVRG), announces it has been selected to contribute newly enhanced monitoring equipment, with a value of GBP0.48 million (including monitoring and consultancy fees) to be installed in a Government National COVID-19 Infrastructure Trial. The multiplex wastewater development trial is expected to last until the end of February 2022 and it is anticipated that revenue from these installations, on successful completion of the trial, will crystalize in the 2022 financial year .

Pandemic Response Equipment

The multiple unit installation consists of six upgraded Microtox(R) toxicity monitoring and new models of the Microtox(R) PD range for SARS-CoV-2 and other pathogen monitoring. In addition, software, data management capability, dashboards, encryption, and new AI models are fully integrated.

Gerry Brandon, CEO of DeepVerge plc, commented:

"Modern Water has been working on this project since March and we are delighted to finally have the Microtox(R) PD form part of a national government covid infrastructural trial for a long-term early-warning solution offering automated real-time and remote monitoring of COVID in wastewater detection.

"We continue to see a rise in interest in our real-time wastewater monitoring solutions from several governments and these installations follow on from last week's announcement of GBP2.2m of Microtox(R) PD shipments. With a growing recognition of the importance of wastewater, as well as our expertise, great science and cross-group teamwork from Modern Water, Labskin and Rinocloud, DeepVerge is well-placed to capitalise on current and future opportunities to work with governments, industries bodies and private companies to create a co-ordinated solution, not only to the current global pandemic but also future health challenges."

Enquiries:

 
                                                  +44 (0) 734 0055 
 DeepVerge plc              Gerry Brandon, CEO     648 
 
 SPARK Advisory Partners 
  Limited 
  (Nominated Adviser)       Neil Baldwin          +44 (0) 113 370 8974 
 
 Turner Pope Investments 
  (TPI) Limited             Andy Thacker/James 
  (Broker)                   Pope                 +44 (0) 20 3657 0050 
 

About DeepVerge plc (www.deepverge.com)

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detect and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.

About Reach announcements

Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word "Reach" in the source column of the News Explorer pages of London Stock Exchange's website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRADKOBBABDDOKB

(END) Dow Jones Newswires

October 28, 2021 02:00 ET (06:00 GMT)

1 Year Integumen Chart

1 Year Integumen Chart

1 Month Integumen Chart

1 Month Integumen Chart
ADVFN Advertorial
Your Recent History
LSE
SKIN
Integumen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220129 03:55:31